Recommendations for the management of patients with obstructive sleep apnoea and hypertension
- PMID: 23397300
- DOI: 10.1183/09031936.00226711
Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Abstract
This article is aimed at addressing the current state-of-the-art in epidemiology, pathophysiology, diagnostic procedures and treatment options for appropriate management of obstructive sleep apnoea (OSA) in cardiovascular (in particular hypertensive) patients, as well as for the management of cardiovascular diseases (in particular arterial hypertension) in OSA patients. The present document is the result of work performed by a panel of experts participating in the European Union COST (Cooperation in Scientific and Technological research) Action B26 on OSA, with the endorsement of the European Respiratory Society and the European Society of Hypertension. In particular, these recommendations are aimed at reminding cardiovascular experts to consider the occurrence of sleep-related breathing disorders in patients with high blood pressure. They are also aimed at reminding respiration experts to consider the occurrence of hypertension in patients with respiratory problems at night.
Comment in
-
Sleep apnoea and hypertension: time for recommendations.Eur Respir J. 2013 Mar;41(3):505-6. doi: 10.1183/09031936.00007213. Eur Respir J. 2013. PMID: 23456933 No abstract available.
Similar articles
-
Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea.J Hypertens. 2012 Apr;30(4):633-46. doi: 10.1097/HJH.0b013e328350e53b. J Hypertens. 2012. PMID: 22406463
-
[Nasal CPAP treatment and hypertension and altered cardiovascular variability associated with obstructive sleep apnea (OSA)].Nihon Rinsho. 2001 May;59(5):983-91. Nihon Rinsho. 2001. PMID: 11392003 Review. Japanese.
-
Hypertension in obstructive sleep apnea: risk and therapy.Expert Rev Cardiovasc Ther. 2009 Jun;7(6):619-26. doi: 10.1586/erc.09.25. Expert Rev Cardiovasc Ther. 2009. PMID: 19505277 Review.
-
[Cardiovascular abnormalities in patients with obstructive sleep apnoea syndrome].Wiad Lek. 2005;58(1-2):78-83. Wiad Lek. 2005. PMID: 15991558 Review. Polish.
-
Cardiovascular consequences of obstructive sleep apnoea.Indian J Med Res. 2010 Feb;131:196-205. Indian J Med Res. 2010. PMID: 20308745 Review.
Cited by
-
Cumulative association of obstructive sleep apnea severity and short sleep duration with the risk for hypertension.PLoS One. 2014 Dec 22;9(12):e115666. doi: 10.1371/journal.pone.0115666. eCollection 2014. PLoS One. 2014. PMID: 25531468 Free PMC article.
-
Prediction model of obstructive sleep apnea-related hypertension: Machine learning-based development and interpretation study.Front Cardiovasc Med. 2022 Dec 5;9:1042996. doi: 10.3389/fcvm.2022.1042996. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36545020 Free PMC article.
-
Precision Medicine in Adult Obstructive Sleep Apnea and Home Diagnostic Testing: Caution in Interpretation of Home Studies Without Clinician Input Is Necessary.Front Neurol. 2022 Feb 21;13:825708. doi: 10.3389/fneur.2022.825708. eCollection 2022. Front Neurol. 2022. PMID: 35265029 Free PMC article.
-
Systemic hypertension in obstructive sleep apnea.J Thorac Dis. 2018 Dec;10(Suppl 34):S4231-S4243. doi: 10.21037/jtd.2018.12.57. J Thorac Dis. 2018. PMID: 30687539 Free PMC article. Review.
-
Obstructive sleep apnea and hypertension: a critical review.Curr Hypertens Rep. 2014 Oct;16(10):482. doi: 10.1007/s11906-014-0482-4. Curr Hypertens Rep. 2014. PMID: 25139780 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical